Healthcare

Fifth wave has outgrown HK’s capacity, but no lockdown for the city: Lam

The government will enhance capacity in various parts of its anti-epidemic effort instead.

Fifth wave has outgrown HK’s capacity, but no lockdown for the city: Lam

The government will enhance capacity in various parts of its anti-epidemic effort instead.

Moderna announces Hong Kong expansion

Its new subsidiary will provide a local presence for improved logistics.

Social distancing measures to see 14-day extension

The period covered will be from 21 January to 20 February.

'Vaccine measures won't be lifted anytime soon': Carrie Lam

Areas of concern include the quarantine hotel and pet shop clusters.

HSBC Life opens online application for insurance plan

Eligible customers who will apply online can get a 20% first-year premium discount.

Quarantine period for local close contacts shortened to 14 days

Following this will be a week of self-monitoring and a virus test on the 19th day. 

What are the social distancing measures in effect in the next 2 weeks?

The government tightened the social measures due to rising coronavirus cases.

Israel and Hong Kong forge fertile business bonds

The Head of Economic and Commercial Mission for the Consulate General of Israel says several of its companies are keen on entering the Hong Kong...

DCH Auriga clinches Team of the Year trophy at the 2021 HKB Management Excellence Awards

The healthcare distributor supported Hong Kong’s COVID-19 vaccination roll out with a successful ultra-low temperature storage and distribution...

Could vaccine passports move the economic needle?

Some reflection is perhaps in order as we approach the second anniversary of COVID-19’s initial outbreak. 

SSY Group sees 11.6% profit growth to $276m in H1

The company declared an interim dividend of HK$0.05 per share.

HK lists Macau as 'at-risk' places for COVID

Residents who stayed in Macau in the last 14 days will be ineligible to return to Hong Kong.

What the new 'event premises' arrangement is all about

This will be in place for two weeks until 4 August.

Zylox-Tonbridge estimates $2.37b gains in global offering

The company has set its offer price at $42.7 per share.

Jacobson Pharma profit climbs nearly 20% to $173.7m

This is despite the 8% revenue drop during the year ended March 2021.